Delivery Order SPE2DB20D3303-SPE2DB22FA0KA

Award Date 8/31/22
Potential Completion Date 9/1/22
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,022.40 firm fixed price delivery order to provide ESTRING 7.5 MCG/DAY (2MG) RINGS. This delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ESTRING 7.5 MCG/DAY (2MG) RINGS. The award, valued at $1,688.88, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical pharmaceutical products to support the healthcare needs of military personnel, veterans,...
This federal contract award, valued at $17,417.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTRING 2 MG VAGINAL RINGS, a pharmaceutical product, with a completion date of June 30, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of ESTRING 7.5 MCG/DAY (2MG) RINGS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,509.33 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of March 21, 2025 and was not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,325.06, is for the delivery of ESTRING 7.5 MCG/DAY (2MG) RINGS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of November 16, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is for the delivery of ESTRING 2 MG VAGINAL RINGS to the Defense Logistics Agency (DLA). The $1,370.40 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 1, 2023, with a completion date of May 2, 2023. The contract is a Delivery Order placed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., by the Defense Logistics Agency (DLA) for the delivery of Estring 7.5 mcg/day (2mg) rings. The contract has a ceiling value of $1,712.44 and an ultimate completion date of April 26, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, with a ceiling value of $1,477.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a delivery order for the supply of ESTRING 7.5 MCG/DAY (2MG) RINGS, a pharmaceutical product. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor on this award, which...
This federal contract award, valued at $1,623.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of ESTRING 7.5 MCG/DAY (2MG) RINGS, a specialty pharmaceutical product. The contract is a firm fixed price delivery order with a performance period through March 11, 2024. It does not have a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,325.72 firm fixed-price delivery order is for the supply of ESTRING 7.5 MCG/DAY (2MG) RINGS, a vaginal estrogen medication. The contract has a period of performance through November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB22FA0KA
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of ESTRING 2 MG VAGINAL RINGS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,310.69 and was awarded on August 31, 2022 as a firm-fixed price delivery order, with a completion date of September 1, 2022. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award does not have a set-aside designation.

Generated 9/6/24, 10:17 AM